Dermatologic adverse events of the PAN-HER tyrosine kinase inhibitor (TKI) PF299804: Assessment by patient-reported outcomes in 2nd/3rd-line and refractory non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Campbell, A. K.; Boyer, M.; Giaccone, G.; Jänne, P. A.; Kim, D. W.; Park, K.; Ramalingam, S.; Reckamp, K. L.; Mundayat, R.; Letrent, S. P.; O'Connell, J.; Lacouture, M. E. |
| Abstract Title: | Dermatologic adverse events of the PAN-HER tyrosine kinase inhibitor (TKI) PF299804: Assessment by patient-reported outcomes in 2nd/3rd-line and refractory non-small cell lung cancer (NSCLC) |
| Meeting Title: | 14th World Conference on Lung Cancer (IASLC) |
| Keywords: | pf-00299804; dermatologic toxicity; patient reported outcomes; egfr tki |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 6 |
| Issue: | 6 Suppl. 2 |
| Meeting Dates: | 2011 Jul 3-7 |
| Meeting Location: | Amsterdam, The Netherlands |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-06-01 |
| Start Page: | S1185 |
| End Page: | S1186 |
| Language: | English |
| ACCESSION: | WOS:000291769800398 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000399290.73317.eb |
| Notes: | --- - Meeting Abstract: P3.041 - S - "Source: Wos" |
